| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 35.55B | 35.07B | 32.87B | 30.73B | 28.55B | 25.45B |
| Gross Profit | 11.11B | 10.92B | 9.93B | 8.82B | 7.87B | 6.68B |
| EBITDA | 4.93B | 4.89B | 4.12B | 3.57B | 3.06B | 2.12B |
| Net Income | 2.41B | 2.34B | 2.13B | 1.55B | 1.11B | 529.11M |
Balance Sheet | ||||||
| Total Assets | 22.15B | 24.49B | 23.45B | 21.51B | 20.08B | 18.91B |
| Cash, Cash Equivalents and Short-Term Investments | 6.91B | 8.12B | 7.67B | 6.31B | 5.21B | 5.31B |
| Total Debt | 466.36M | 482.68M | 520.86M | 551.73M | 609.56M | 1.11B |
| Total Liabilities | 7.99B | 9.30B | 9.19B | 8.97B | 8.64B | 7.91B |
| Stockholders Equity | 14.15B | 15.18B | 14.26B | 12.53B | 11.43B | 11.00B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.25B | 2.70B | 2.37B | 2.04B | 1.63B |
| Operating Cash Flow | 0.00 | 3.89B | 3.64B | 2.91B | 2.65B | 1.90B |
| Investing Cash Flow | 0.00 | -1.34B | -2.36B | -1.13B | -1.70B | -439.73M |
| Financing Cash Flow | 0.00 | -2.12B | -761.14M | -687.86M | -1.04B | 1.95B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥17.93B | 13.55 | ― | 3.81% | 9.96% | 252.72% | |
75 Outperform | ¥45.04B | 28.75 | ― | 2.28% | 7.30% | 60.93% | |
71 Outperform | ¥33.48B | 14.97 | ― | 5.00% | ― | ― | |
71 Outperform | ¥40.77B | 8.14 | ― | 3.55% | 4.95% | 9.43% | |
70 Outperform | ¥38.81B | 18.91 | ― | 2.56% | 7.41% | 22.70% | |
69 Neutral | ¥2.31B | 1.39 | ― | 3.34% | 1.92% | 71.20% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |